FindTrial
Sign In

Molecular Characterization and Genomic Profiling of Multidrug and Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa, and Antifungal-Resistant Candida auris from Critical and Non-Critical Care Isolates: A Multicentric Pilot Study from Eastern India

Molecular Characterization and Genomic Profiling of Multidrug and Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa, and Antifungal-Resistant Candida auris from Critical and Non-Critical Care Isolates: A Multicentric Pilot Study from Eastern India - No

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/101905
Enrollment
120
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Nil: Nil

Sponsors

Institute of Medical Science and SUM Hospital, (Deemed to be) SOA University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 - Confirmed MDR culture-positive isolates of A. baumannii, P. aeruginosa, and C. auris. 2 - Samples from both critical and non-critical care wards.

Exclusion criteria

Exclusion criteria: 1 - Culture grown for more than 72 hours. 2 - Samples not having clear information of site and specimen type. 3 - All susceptible isolates of A. baumannii, P. aeruginosa, and C. auris.

Design outcomes

Primary

MeasureTime frame
Prevalence of key AMR genes in ICU and non ICU isolates of all the centres Detection of novel or unreported mutations. Gene phenotype correlation for resistance strength (Single drug-resistance [SDR], Multidrug-resistance [MDR], Extensively drug-resistant [XDR] and Pandrug-resistant [PDR]). Comparative AMR genes in critical and non-critical care isolates Timepoint: 7 months—

Secondary

MeasureTime frame
Comparative AMR trends among institutions. Association of AMR determinants with infection site and specimen type. Timepoint: 4 months—

Countries

India

Contacts

Public ContactSiddhant Saswat

Institute of Medical Science and SUM Hospital, SOA University

siddhantsaswat@gmail.com8093441009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026